ClinicalTrials.Veeva

Menu

The Use of Machine Learning Techniques for the Differential Diagnosis Between Eosinophilic Granulomatosis With Polyangiitis and Hypereosinophilic Syndrome

I

Institute of Hospitalization and Scientific Care (IRCCS)

Status

Enrolling

Conditions

EGPA - Eosinophilic Granulomatosis With Polyangiitis
HES - Hypereosinophilic Syndrome

Treatments

Procedure: Blood draw for the laboratory assessment

Study type

Interventional

Funder types

Other

Identifiers

NCT07275190
AI_EH_resub

Details and patient eligibility

About

The purpose of this study is to collect clinical, laboratory, and instrumental data from patients with eosinophilic granulomatosis with polyangiitis or hypereosinophilic syndrome, which will then be analyzed using artificial intelligence techniques with the aim of identifying characteristics that differentiate the two diseases and can predict the response to the treatment plan.

Enrollment

60 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. 18 years of age or over
  2. A diagnosis of EGPA or HES
  3. Willing and able to give informed written consent, or willing to give permission for a nominated friend or relative to provide written informed assent if they are unable to do so because of physical disabilities

Exclusion criteria

  1. Lack of a confirmed diagnosis of EGPA or HES.
  2. Other causes of eosinophilia

Trial design

Primary purpose

Other

Allocation

N/A

Interventional model

Parallel Assignment

Masking

None (Open label)

Trial contacts and locations

1

Loading...

Central trial contact

Alessandra Milanesi; Carlomaurizio Montecucco

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems